The PDL Centre is self-sufficient to carry out the entire gamut of activities to design and develop new products: preformulation, prototype development, analytical development and packaging development – including processing of clinical study batches.
The Centre has a 2000 square meters working area and has specific areas classified as per the GMP requirement for oral, topical dosage forms and sterile areas for sterile products and microbiological analysis.
It works with a highly-qualified and experienced team of scientists, striving to uncover a wide range of therapeutics to fight a range of diseases.
The laboratories are equipped with world-class equipment and instruments, most of them automated, PLC based and from internationally reputed manufacturers. All major analytical instruments are compliant to the FDA Title 21 of the Code of Federal Regulations (CFR) part 11.